Image of a vial of the inactivated Sinopharm COVID-19 vaccine (Vero Cell).
The inactivated COVID-19 vaccine (Vero Cell) manufactured by Sinopharm, China, is designed to prevent coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus. Once the inactivated virus contained in the vaccine is injected into the body, it stimulates the production of antibodies, preparing the body to respond to a SARS-CoV-2 infection. Aluminium hydroxide is added to the vaccine formulation to enhance the immune system response.
Specifically:
+ Vaccine name: Inactivated COVID-19 Vaccine (Vero Cell) (also known as Inactivated SARS-CoV-2 Vaccine (Vero Cell)) by Sinopharm.
+ Active ingredient, concentration/strength: Each dose (0.5 ml) contains 6.5 U of antigen.
+ Pharmaceutical form: Solution for injection.
+ Packaging presentation: Box of 1 vial or 3 vials; each vial contains a single 0.5 ml dose.
Manufacturer and Country of Origin: Beijing Institute of Biological Products Co., Ltd., China National Biotec Group (CNBG) / Sinopharm – China.
Clinical trial results demonstrate that the inactivated Sinopharm COVID-19 vaccine (Vero Cell) has a protective efficacy of 79% against COVID-19.
Vaccine Storage
Store at 2ºC–8ºC and do not freeze the vaccine.
Unopened vials stored at 2ºC–8ºC may be used within 24 months from the date of manufacture.
Opened vials must be used within 6 hours of opening and stored at 2ºC–8ºC. Protect from direct sunlight.
Source: National COVID-19 Vaccination Operational Guidelines, National Immunisation Programme